Ontario Genomics

Ontario Genomics welcomes two new board members and appoints Interim Chair

November 7, 2018

Ontario Genomics is pleased to announce the appointment of Dr. Tom Corr and Dr. Diane Gosselin to its Board.

These highly accomplished individuals bring a wealth of insight, experience and expertise in areas crucial to our business that will contribute to fulfilling the mission and achieving the strategic objectives of Ontario Genomics.

Tom Corr is President and CEO of Ontario Centres of Excellence and brings more than 40 years of experience in the technology transfer, ITC, entrepreneurship, academic and venture capital sectors; and Diane Gosselin is President and Chief Executive Officer of CQDM. As a scientific and accomplished leader, Diane has been passionately committed to the financing of innovative biomedical research for over 20 years.

Ontario Genomics is also pleased to announce the appointment of Dr. Jack Gauldie as Interim Chair of the Board, following the retirement of Dr. Brian Underdown who has served as Board Chair since 2011. Jack Gauldie has been an esteemed member of the Ontario Genomics’ Board of Directors for the last seven years.

“The experience and skills of our new members are a fantastic complement to the strengths of our current Board and will assist us as we work towards Ontario Genomics’ future. I look forward to working closely with the Board to develop and execute on a vision that will position genomics technologies as promising solutions to some of our most pressing challenges across Ontario’s economy,” said Dr. Bettina Hamelin, President and CEO of Ontario Genomics.

Ontario Genomics thanks retiring Chair, Dr. Brian Underdown, for his sage leadership, and Board members Dr. Maurice Bitran, Dr. Scott Tanner, and Dr. Cal Stiller for their invaluable service and contributions to Ontario Genomics and the province’s genomics ecosystem.

For more information and detailed biographical notes visit our Board of Directors page.